The plasma carnitine concentration regulates renal OCTN2 expression and carnitine transport in rats

European Journal of Pharmacology

Volumn 635, Issue 1-3, 2010, Pages 171-176

  Schürch, Regula ^a,b   Todesco, Liliane ^a   Novakova, Katarina ^a   Mevissen, Meike ^b   Stieger, Bruno ^c   Krähenbühl, Stephan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

N trimethyl hydrazine 3 propionate; OCTN2; Renal carnitine reabsorption; Secondary carnitine deficiency

Indexed keywords

CARNITINE; CARRIER PROTEIN; MESSENGER RNA; N TRIMETHYL HYDRAZINE 3 PROPIONATE; PROPIONIC ACID DERIVATIVE; PROTEIN OCTN2; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARNITINE DEFICIENCY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GLOMERULUS FILTRATION; INTESTINE MUCOSA; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE EPITHELIUM; LIVER LEVEL; MALE; MUSCLE LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SKELETAL MUSCLE;

ANIMALS; BIOLOGICAL TRANSPORT; CARNITINE; CELL LINE; CELL MEMBRANE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; METHYLHYDRAZINES; ORGANIC CATION TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; VITAMIN B DEFICIENCY;

EID: 77952321987     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.02.045     Document Type: Article

References (33)

1. Bensadoun A., Weinstein D. Assay of proteins in the presence of interfering materials. Anal. Biochem. 1976, 70:241-250.
2. Biber J., Stieger B., Haase W., Murer H. A high yield preparation for rat kidney brush border membranes. Different behaviour of lysosomal markers. Biochim. Biophys. Acta 1981, 647:169-176.
3. Brass E.P., Hoppel C.L. Carnitine metabolism in the fasting rat. J. Biol. Chem. 1978, 253:2688-2693.
4. Brass E.P., Hoppel C.L. Relationship between acid-soluble carnitine and coenzyme A pools in vivo. Biochem. J. 1980, 190:495-504.
5. Bremer J. Carnitine-metabolism and functions. Physiol. Rev. 1983, 63:1420-1480.
6. Friolet R., Hoppeler H., Krahenbuhl S. Relationship between the coenzyme A and the carnitine pools in human skeletal muscle at rest and after exhaustive exercise under normoxic and acutely hypoxic conditions. J. Clin. Invest. 1994, 94:1490-1495.
7. Fritz I.B. The effects of muscle extracts on the oxidation of palmitic acid by liver slices and homogenates. Acta Physiol. Scand. 1955, 34:367-385.
8. Hirai T., Fukui Y., Motojima K. PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine. Biol. Pharm. Bull. 2007, 30:2185-2190.
9. Kato Y., Sai Y., Yoshida K., Watanabe C., Hirata T., Tsuji A. PDZK1 directly regulates the function of organic cation/carnitine transporter OCTN2. Mol. Pharmacol. 2005, 67:734-743.
10. Koch A., Konig B., Stangl G.I., Eder K. PPAR alpha mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis. Exp. Biol. Med. (Maywood) 2008, 233:356-365.
11. Koepsell H., Lips K., Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 2007, 24:1227-1251.
12. Lombard K.A., Olson A.L., Nelson S.E., Rebouche C.J. Carnitine status of lactoovovegetarians and strict vegetarian adults and children. Am. J. Clin. Nutr. 1989, 50:301-306.
13. Luci S., Hirche F., Eder K. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues. Ann. Nutr. Metab. 2008, 52:58-67.
14. Maeda T., Wakasawa T., Funabashi M., Fukushi A., Fujita M., Motojima K., Tamai I. Regulation of OCTN2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha. Biol. Pharm. Bull. 2008, 31:1230-1236.
15. Nezu J., Tamai I., Oku A., Ohashi R., Yabuuchi H., Hashimoto N., Nikaido H., Sai Y., Koizumi A., Shoji Y., Takada G., Matsuishi T., Yoshino M., Kato H., Ohura T., Tsujimoto G., Hayakawa J., Shimane M., Tsuji A. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat. Genet. 1999, 21:91-94.
16. Rahbeeni Z., Vaz F.M., Al-Hussein K., Bucknall M.P., Ruiter J., Wanders R.J., Rashed M.S. Identification of two novel mutations in OCTN2 from two Saudi patients with systemic carnitine deficiency. J. Inherit. Metab. Dis. 2002, 25:363-369.
17. Rebouche C.J., Mack D.L. Sodium gradient-stimulated transport of l-carnitine into renal brush border membrane vesicles: kinetics, specificity, and regulation by dietary carnitine. Arch. Biochem. Biophys. 1984, 235:393-402.
18. Rebouche C.J., Lombard K.A., Chenard C.A. Renal adaptation to dietary carnitine in humans. Am. J. Clin. Nutr. 1993, 58:660-665.
19. Ringseis R., Posel S., Hirche F., Eder K. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Pharmacol. Res. 2007, 56:175-183.
20. Ringseis R., Luci S., Spielmann J., Kluge H., Fischer M., Geissler S., Wen G., Hirche F., Eder K. Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species. Eur. J. Pharmacol. 2008, 583:11-17.
21. Seth P., Wu X., Huang W., Leibach F.H., Ganapathy V. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function. J. Biol. Chem. 1999, 274:33388-33392.
22. Spaniol M., Brooks H., Auer L., Zimmermann A., Solioz M., Stieger B., Krahenbuhl S. Development and characterization of an animal model of carnitine deficiency. Eur. J. Biochem. 2001, 268:1876-1887.
23. Spaniol M., Kaufmann P., Beier K., Wuthrich J., Torok M., Scharnagl H., Marz W., Krahenbuhl S. Mechanisms of liver steatosis in rats with systemic carnitine deficiency due to treatment with trimethylhydraziniumpropionate. J. Lipid Res. 2003, 44:144-153.
24. Stadler D.D., Bale J.F., Chenard C.A., Rebouche C.J. Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans. Metabolism 1999, 48:74-79.
25. Stephens F.B., Constantin-Teodosiu D., Laithwaite D., Simpson E.J., Greenhaff P.L. Insulin stimulates l-carnitine accumulation in human skeletal muscle. FASEB J. 2006, 20:377-379.
26. Stieger B., Stange G., Biber J., Murer H. Transport of l-lysine by rat renal brush border membrane vesicles. Pflugers Arch. 1983, 397:106-113.
27. Stieger B., O'Neill B., Krahenbuhl S. Characterization of l-carnitine transport by rat kidney brush-border-membrane vesicles. Biochem. J. 1995, 309(Pt 2):643-647.
28. Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 1998, 273:20378-20382.
29. Treem W.R., Stanley C.A., Finegold D.N., Hale D.E., Coates P.M. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N. Engl. J. Med. 1988, 319:1331-1336.
30. van Vlies N., Ferdinandusse S., Turkenburg M., Wanders R.J., Vaz F.M. PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochim. Biophys. Acta 2007, 1767:1134-1142.
31. Vernez L., Dickenmann M., Steiger J., Wenk M., Krahenbuhl S. Effect of l-carnitine on the kinetics of carnitine, acylcarnitines and butyrobetaine in long-term haemodialysis. Nephrol. Dial. Transplant. 2006, 21:450-458.
32. Wang Y., Ye J., Ganapathy V., Longo N. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2356-2360.
33. Yabuuchi H., Tamai I., Nezu J., Sakamoto K., Oku A., Shimane M., Sai Y., Tsuji A. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J. Pharmacol. Exp. Ther. 1999, 289:768-773.